Paul Brennan is a Grit DAily contributor and president/CEO of NervGen Pharma Corp., a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases. He can be reached at pb[email protected]
More articles by Paul Brennan
Paul Brennan
on January 7, 2021
The Acceleration of Alzheimer’s Disease Drug Innovations
Paul Brennan
on December 23, 2020
Therapeutics Innovation in the Era of a Pandemic
Paul Brennan
on November 17, 2020